{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:21Z","timestamp":1791275781916,"version":"4.1.0"},"reference-count":136,"publisher":"Baishideng Publishing Group Inc.","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2006]]},"DOI":"10.3748\/wjg.v12.i30.4819","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T01:03:59Z","timestamp":1509930239000},"page":"4819","source":"Crossref","is-referenced-by-count":280,"title":["Extraintestinal manifestations and complications in inflammatory bowel diseases"],"prefix":"10.3748","volume":"12","author":[{"given":"Katja S","family":"Rothfuss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard F","family":"Stange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus R","family":"Herrlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03756.x"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200405000-00005"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.021"},{"key":"ref4","unstructured":"Mendoza JL, Lana R, Taxonera C, Alba C, Izquierdo S, D&iacute;az-Rubio M. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Med Clin (Barc) 2005;125:297-300."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology 1994;107:103-108.","DOI":"10.1016\/0016-5085(94)90066-3"},{"key":"ref6","unstructured":"Oshitani N, Watanabe K, Nakamura S, Higuchi K, Arakawa T. [Extraintestinal complications in patients with ulcerative colitis]. Nihon Rinsho 2005;63:874-878."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.738"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178675"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35396"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70209-5"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.17.11.906"},{"key":"ref12","unstructured":"van Milligen de Wit AW, van Deventer SJ, Tytgat GN. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am J Gastroenterol 1995;90:893-900."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.021774"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197609000-00004"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.3.387"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01662.x"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-6618(02)00033-6"},{"key":"ref18","unstructured":"de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 2000;27:2860-2865."},{"key":"ref19","unstructured":"Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L, Schatteman L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995;22:2266-2272."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.8.767"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.012450"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/ar1012"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.1.74"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/art.20977"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/art.21426"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:791-794.","DOI":"10.1053\/gast.2003.50107"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-10-200011210-00012"},{"key":"ref28","unstructured":"Satsangi J. Compston, Osteoporosis associated with inflammatory bowel disease, in Inflammatory bowel disease. Churchill Livingstone 2003;637-648."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3109\/00365528109181952"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.2.223"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.4.410"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296010"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-233.","DOI":"10.1136\/gut.40.2.228"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709000199"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.468_q.x"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2004.09.006"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200405000-00007"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.027"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-6009(08)80046-3"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/BF02106094"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-996-0070-y"},{"key":"ref42","unstructured":"Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med 2004;95:469-480."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310007873"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90068-3"},{"key":"ref45","unstructured":"Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Br&uuml;ckel J, B&ouml;hm BO, Adler G, Reinshagen M. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors]. Z Gastroenterol 1999;37:5-12."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00364.x"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.2.209"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00321.x"},{"key":"ref49","unstructured":"Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609-614."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16518"},{"key":"ref51","unstructured":"Adachi J, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, Craig GL, Kaminska E, Sebaldt RJ, Papaioannou A. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol 1994;21:1922-1926."},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, Zizic TM, Wallach S, Sewell KL, Lukert BP. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 1999;42:2309-2318.","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.6.1006"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390502"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.11.1543"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91318-1"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.12.1546"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Chiba T, Isomura I, Suzuki A, Morita A. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 2005;32:199-203.","DOI":"10.1111\/j.1346-8138.2005.tb00745.x"},{"key":"ref59","unstructured":"Galun E, Flugelman MY, Rachmilewitz D. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 1986;81:988-989."},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07581.x"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/PL00002176"},{"key":"ref62","unstructured":"Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 1982;14:356-360."},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05514.x"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.903"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991;100:1385-1391.","DOI":"10.1016\/0016-5085(91)70028-V"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409103626"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50156"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-2-200101160-00008"},{"key":"ref69","unstructured":"Broom&eacute; U, L&ouml;fberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995;22:1404-1408."},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709025107"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199312000-00004"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01287.x"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.9.1076"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:27:3:171"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200023050-00006"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3109\/00365528709089774"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.10.1192"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200411000-00012"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199604000-00010"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800660705"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609006775"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Angelini G, Cavallini G, Bovo P, Brocco G, Castagnini A, Lavarini E, Merigo F, Tallon N, Scuro LA. Pancreatic function in chronic inflammatory bowel disease. Int J Pancreatol 1988;3:185-193.","DOI":"10.1007\/BF02798930"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90226-0"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1046\/j.1572-0241.2003.04026.x"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.025411"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.3.183"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005541028045"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199810000-00007"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.3.389"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000172242.19675.33"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Stokke KT, Teisberg PA, Myhre E, Hovig T, Flatmark A, Gjone E. Nephrotic syndrome in ulcerative colitis. Scand J Gastroenterol 1976;11:571-576.","DOI":"10.1080\/00365521.1976.12097153"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198611000-00026"},{"key":"ref93","unstructured":"Kullmann F, Kullmann M, Leser HG, Kr&auml;mer BK, Riegger AJ, Sch&ouml;lmerich J. [Nephrotic syndrome as the initial symptom of Crohn disease]. Z Gastroenterol 1996;34:757-762."},{"key":"ref94","unstructured":"Dhiman RK, Poddar U, Sharma BC, Arora P, Saraswat VA, Pandey R, Naik SR. Membranous glomerulonephritis in association with ulcerative colitis. Indian J Gastroenterol 1998;17:62."},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6903.540"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.92264000.x"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.4.536"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.016"},{"key":"ref99","unstructured":"Kreisel W, Wolf LM, Grotz W, Grieshaber M. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:461-468."},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01041.x"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00940.x"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199372030-00003"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1976.03630040056012"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01843.x"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1378\/chest.87.3.363"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05473.x"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200310000-00006"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200303000-00004"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.5.9801070"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1159\/000029413"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-1-17"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199711000-00018"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00.15104100"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1378\/chest.81.6.766"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00267402"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Tanigawa K, Sugiyama K, Matsuyama H, Nakao H, Kohno K, Komuro Y, Iwanaga Y, Eguchi K, Kitaichi M, Takagi H. Mesalazine-induced eosinophilic pneumonia. Respiration 1999;66:69-72.","DOI":"10.1159\/000029341"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992;103:954-960.","DOI":"10.1016\/0016-5085(92)90029-X"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.036"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613037"},{"key":"ref120","unstructured":"Satsangi J. Allez, Extra-intestinal manifetations of inflammatory bowel disease: others., in Inflammatory bowel disease, S.L.R. Churchill Livingstone 2003;591-697."},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909143211115"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90629-8"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.4065\/75.8.802"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199201000-00011"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.3.416"},{"key":"ref126","unstructured":"Sedwick LA, Klingele TG, Burde RM, Behrens MM. Optic neuritis in inflammatory bowel disease. J Clin Neuroophthalmol 1984;4:3-6."},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.8.1414"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00720.x"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Akbayir N, Cali\u015f AB, Alkim C, S&ouml;kmen HM, Erdem L, Ozbal A, B&ouml;l&uuml;kba\u015f F, Akbayir N. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Dig Dis Sci 2005;50:1938-1945.","DOI":"10.1007\/s10620-005-2964-3"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90013-6"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.022"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051847"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;362-368.","DOI":"10.1056\/NEJMoa051586"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12&lt;2862::ID-ART474&gt;3.0.CO;2-W"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Mejico LJ. Infliximab-associated retrobulbar optic neuritis. Arch Ophthalmol 2004;122:793-794.","DOI":"10.1001\/archopht.122.5.793"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200401000-00004"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i30\/4819.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T13:33:53Z","timestamp":1659792833000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i30\/4819.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":136,"aliases":["10.3748\/wjg.12.4819","10.3748\/wjg.12.4819","10.3748\/wjg.12.4819"],"journal-issue":{"issue":"30","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v12.i30.4819","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}